– USA, CA – Eargo, a US-based medical device company, has raised $71m in an equity financing round led by new co-investors Gilde Healthcare and Longitude Capital joined by the existing investors New Enterprise Associates, the Charles and Helen Schwab Foundation and Nan Fung Life Sciences.
Concurrent with the financing, Gilde Healthcare general partner Geoff Pardo and Longitude Capital founder and managing director Juliet Bakker will join Eargo’s board of directors as part of the deal.
The funds will be used to accelerate the commercialization of its direct-to-consumer hearing loss solution.
Geoff Pardo said: “Eargo has revolutionized the hearing loss solution, offering a highly advanced hearing solution available through a virtual clinic model. We are excited to be a part of the Eargo team and their vision to transform this market, bringing it into the 21st century.”
Juliet Bakker said: “A hearing solution developed with the consumer in mind was long overdue. Eargo has truly put the consumer first, from consultations and solution design to the buying experience and highly rated customer support. We are delighted to partner with Eargo to help fuel the growth of this unique business.”
Eargo offers virtually invisible, rechargeable, completely-in-canal, the Food and Drug Administration-regulated, exempt Class I hearing aid, along with online hearing screening and telecare consultation and support. Consumers can purchase the solution online or over the phone. They can also have personalized consultation and support from licensed hearing professionals through phone, text, email or video chat.
Eargo president and CEO Christian Gormsen said: “We are pleased to close on this financing round, which provides us with significant capital to fund our growth. While our business was performing well before Covid-19, the pandemic accelerated consumer demand for our hearing loss solution. More consumers who are reluctant to purchase their hearing aids through the traditional brick and mortar clinics have recognized the benefits of our solution.”
It is estimated that approximately 43 million people suffer from hearing loss in the US. However, only 27% of the affected people own hearing aid due to the stigma and inconvenience of the traditional clinic-based model.
For more information: https://eargo.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.